ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer.
暂无分享,去创建一个
H. Pannu | D. Gaffney | A. Wolfson | T. Shipp | P. Glanc | C. Zelop | M. Elshaikh | H. Royal | L. Simpson | N. Lalwani | M. Javitt | C. Siegel | A. Wahl | Y. B. Kim | L. Lee | Ted Dubinsky
[1] E. Haacke,et al. Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies , 2013, European Radiology.
[2] M. Senda,et al. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [18F]FDG PET/CT in endometrial cancer , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[3] Qingli Zhu,et al. Imaging of Endometrial Carcinoma Using Contrast‐Enhanced Sonography , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[4] W. Small,et al. ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. , 2011, Ultrasound quarterly.
[5] Yajun Li,et al. The Value of the Apparent Diffusion Coefficient in Differentiating Stage IA Endometrial Carcinoma From Normal Endometrium and Benign Diseases of the Endometrium: Initial Study at 3-T Magnetic Resonance Scanner , 2010, Journal of computer assisted tomography.
[6] S. Galimberti,et al. Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T , 2010, European Radiology.
[7] K. Matsuzaki,et al. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion , 2009, Acta radiologica.
[8] T. Murakami,et al. MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: Comparison with imaging at 1.5 T , 2009, Journal of magnetic resonance imaging : JMRI.
[9] V. Torri,et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.
[10] S. Pecorelli. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .
[11] M. Parmar,et al. Lymphadenectomy in endometrial cancer – Authors' reply , 2009, The Lancet.
[12] O. Kilickesmez,et al. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones , 2009, Acta radiologica.
[13] M. Parmar,et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.
[14] E. Sala,et al. Added Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Advanced Stage Disease in Patients With Endometrial Carcinoma , 2009, International Journal of Gynecologic Cancer.
[15] F. Mazzariol,et al. Efficacy of contrast-enhanced CT in assessing the endometrium. , 2008, AJR. American journal of roentgenology.
[16] K. Sugimura,et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. , 2008, AJR. American journal of roentgenology.
[17] T. Gungor,et al. The evaluation of endometrial tumors by transvaginal and Doppler ultrasonography , 2008, Archives of Gynecology and Obstetrics.
[18] G. Ferrandina,et al. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[19] Andrea Mariani,et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. , 2008, Gynecologic oncology.
[20] M. Bajka,et al. [Measuring the death of invasion of endometrial carcinoma. Preoperative transvaginal ultrasound and correlation with intraoperative and histopathologic findings--a prospective study]. , 2008, Ultraschall in der Medizin.
[21] K. Sugimura,et al. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer , 2008, Annals of nuclear medicine.
[22] M. Yen,et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. , 2008, AJR. American journal of roentgenology.
[23] G. Ligabue,et al. 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. , 2008, AJR. American journal of roentgenology.
[24] S. Fujii,et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results , 2008, European Radiology.
[25] C. Tsampoulas,et al. Local staging of endometrial carcinoma: role of multidetector CT , 2008, European Radiology.
[26] D. Kim,et al. Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients , 2007, International Journal of Gynecologic Cancer.
[27] E. Miyagi,et al. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer , 2006, International Journal of Gynecologic Cancer.
[28] E. Sala,et al. [MRI of malignant neoplasms of the uterine corpus and cervix]. , 2007, Radiologia.
[29] D. Levine,et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology , 2007, International Journal of Gynecologic Cancer.
[30] A. Félix,et al. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and histopathologic evaluation , 2007, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[31] S. Dobbs,et al. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. , 2006, Gynecologic oncology.
[32] R. Reznek,et al. Evaluation of endometrial carcinoma on magnetic resonance imaging , 2006, International Journal of Gynecologic Cancer.
[33] G. Ambrosini,et al. Risks and usefulness of sonohysterography in patients with endometrial carcinoma. , 2006, American journal of obstetrics and gynecology.
[34] P. Grigsby,et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. , 2004, Gynecologic oncology.
[35] G. Scambia,et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. , 2004, Radiology.
[36] K. Togashi,et al. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer , 2003, Annals of nuclear medicine.
[37] R. Hustinx,et al. Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[38] I. Szabó,et al. Assessment of myometrial and cervical invasion of endometrial cancer by transvaginal sonography. , 2001, European journal of gynaecological oncology.
[39] S. Costantini,et al. [The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma]. , 2001, La Radiologia medica.
[40] D. Arko,et al. High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[41] A. Gadducci,et al. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. , 2000, Anticancer research.
[42] R. Buller,et al. Computed Tomography in Endometrial Carcinoma , 2000, Obstetrics and gynecology.
[43] J. Alcázar,et al. Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk , 2000, Acta obstetricia et gynecologica Scandinavica.
[44] M. Segal,et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. , 1999, Radiology.
[45] N. Sakuragi,et al. A clinical and pathologic study on para‐aortic lymph node metastasis in endometrial carcinoma , 1997, Journal of surgical oncology.
[46] K. Papadakis,et al. Patterns of pulmonary metastasis from uterine cancer. , 1996, Oncology.
[47] J. Brown,et al. Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection. , 1996, AJR. American journal of roentgenology.
[48] Y. Song,et al. Detection of Deep Myometrial Invasion in Endometrial Carcinoma: Comparison of Trans vaginal Ultrasound, CT, and MRI , 1995, Journal of computer assisted tomography.
[49] H. Kosuge,et al. [The accuracy of computed tomography and magnetic resonance imaging in evaluating the extent of endometrial carcinoma]. , 1995, Nihon Sanka Fujinka Gakkai zasshi.
[50] F. Kommoss,et al. Transvaginal sonography of myometrial invasion depth in endometrial cancer , 1994, Acta obstetricia et gynecologica Scandinavica.
[51] C. Belloni,et al. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. , 1993, AJR. American journal of roentgenology.
[52] J. Shepherd. Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.
[53] J. Masselot,et al. Lymphography in the initial evaluation of endometrial carcinoma , 1988, Gynecologic oncology.
[54] L. Blumenson,et al. Paraaortic Lymph Node Evaluation in Stage I Endometrial Carcinoma , 1982, Obstetrics and gynecology.
[55] H. Salvesen,et al. Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. , 2012, Clinical radiology.
[56] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[57] P. Stentella,et al. FIGO Stage I endometrial carcinoma: evaluation of lung metastases and follow-up. , 2008, European journal of gynaecological oncology.
[58] R. Reznek,et al. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. , 2007, Clinical radiology.
[59] Y. Yamashita,et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. , 1993, AJR. American journal of roentgenology.
[60] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.